Celontin
NDC 0071-0525, methsuximide, capsule, from Parke-Davis Div of Pfizer Inc.
- Product NDC
- 0071-0525
- Status
- Listed
- Labeler
- Parke-Davis Div of Pfizer Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA010596
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0071-0525 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHSUXIMIDE300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0071-0525-24 | 00071052524 | 100 CAPSULE in 1 BOTTLE (0071-0525-24) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/64a6ee88-c6b1-4e13-8208-b6772ef65a74NADAC price for package 00071052524
GET /v1/drugs/nadac/00071052524
Use it
Look up 0071-0525 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0071-0525 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0071-0525. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.